Response to the letter to the editor on "Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients"
J Med Virol
.
2023 Jul;95(7):e28945.
doi: 10.1002/jmv.28945.
Authors
Yi-Chen Chen
1
,
Chung-Han Ho
1
2
3
,
Ting-Hui Liu
4
,
Jheng-Yan Wu
5
,
Po-Yu Huang
6
,
Ya-Wen Tsai
7
,
Chih-Cheng Lai
8
9
Affiliations
1
Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan.
2
Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
3
Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
4
Department of General Internal Medicine, Chi Mei Medical Center, Tainan City, Taiwan.
5
Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan.
6
Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
7
Center for Integrative Medicine, Chi Mei Medical Center, Tainan, Taiwan.
8
Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
9
School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
PMID:
37431965
DOI:
10.1002/jmv.28945
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19* / complications
Herpes Zoster* / complications
Herpes Zoster* / epidemiology
Humans
Retrospective Studies